Last updated: September 2, 2018
Sponsor: Universidad de Valparaiso
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT03531359
UV-1-2018
Ages 2-10 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Children aged 2-10 years, under major surgery ambulatory program at Hospital Carlos VanBuren, with no contraindication for the use of midazolam.
Exclusion
Exclusion Criteria: Patients with cognitive impairment or sensory deficit Patients with previous history ofmajor surgery will also be excluded Patients with myastenia "Hard airway" History ofparoxystic reaction to benzodiazepines Attentional deficit hyperactivity disorder Sleepaphnea Full stomach Adenotonsillar hypertrophy Respiratory acute infections
Study Design
Total Participants: 112
Study Start date:
July 04, 2018
Estimated Completion Date:
July 30, 2020
Study Description
Connect with a study center
Hospital Carlos Van Buren
Valparaiso, 2341131
ChileActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.